0000950170-24-058878.txt : 20240513 0000950170-24-058878.hdr.sgml : 20240513 20240513180734 ACCESSION NUMBER: 0000950170-24-058878 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240510 FILED AS OF DATE: 20240513 DATE AS OF CHANGE: 20240513 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Treace John T. CENTRAL INDEX KEY: 0001856380 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40355 FILM NUMBER: 24940691 MAIL ADDRESS: STREET 1: C/O TREACE MEDICAL CONCEPTS, INC. STREET 2: 203 FORT WADE ROAD, SUITE 150 CITY: PONTE VEDRA STATE: FL ZIP: 32081 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TREACE MEDICAL CONCEPTS, INC. CENTRAL INDEX KEY: 0001630627 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 471052611 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 PALMETTO PARK PLACE CITY: PONTE VEDRA STATE: FL ZIP: 32081 BUSINESS PHONE: (904) 373-5940 MAIL ADDRESS: STREET 1: 100 PALMETTO PARK PLACE CITY: PONTE VEDRA STATE: FL ZIP: 32081 4 1 ownership.xml 4 X0508 4 2024-05-10 0001630627 TREACE MEDICAL CONCEPTS, INC. TMCI 0001856380 Treace John T. C/O TREACE MEDICAL CONCEPTS, INC. 100 PALMETTO PARK PLACE PONTE VEDRA FL 32081 true true true false Chief Executive Officer false Common Stock 2024-05-10 4 P false 150000 4.5792 A 5943095 D Common Stock 2024-05-13 4 P false 150000 4.5566 A 6093095 D Common Stock 1605000 I By spouse Common Stock 1471250 I By spouse as co-trustee of a trust Common Stock 1839063 I as trustee of a trust Common Stock 408816 I as co-trustee of a trust The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.4700 to $4.7500 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote. Includes 196,646 restricted stock units The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.3900 to $4.6400 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote. The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee. The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as trustee or co-trustee. /s/ Lisa O. Taylor as Attorney in Fact for John T. Treace 2024-05-13